Karyopharm Therapeutics – The salary is the best part

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory

Immagine del profilo

paragonabile Awards

Karyopharm Therapeutics società ha sostenuto

Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più

Questa società sta accettando feedback da dipendenti verificate DIPENDENTE PARTECIPANTI: 90

Nominale Complessiva: 2628

Amministratore delegato: Richard Paulson

The salary is the best part

Other Employee Reviews for Karyopharm Therapeutics

Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda

One of the best career choices I have ever made

Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda

I have only been at the company for three months now. However in the 3 months I have worked on numerous projects across a variety of different departments. My current position (corporate communications) has allowed me to create and work with so many different employees with different backgrounds .

Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda

challenging, rewarding, exciting, collaborative, meaningful

Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda

I am challenged, I learn a lot, and I make a difference. These are the key pieces for me!

Descrivere brevemente la vostra esperienza complessiva presso la vostra azienda

A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.

×

Rate your company